Construction of recombinant adenovirus expressing <i>EGFRvIII</i> extracellular domain gene and preparation of single domain antibody.

Huimin Zhang; Jiaqi XU; Yi Cheng; Shan FU; Yanlong Liu; Yujing HU; Yanan DU; Fuxiang Bao

Return

Construction of recombinant adenovirus expressing EGFRvIII extracellular domain gene and preparation of single domain antibody.

Author: Huimin ZHANG ¹ ; Jiaqi XU ¹ ; Yi CHENG ¹ ; Shan FU ¹ ; Yanlong LIU ¹ ; Yujing HU ¹ ; Yanan DU ¹ ; Fuxiang BAO ¹
Author Information

1. College of Veterinary Medicine, Inner Mongolia Agricultural University, Hohhot 010018, Inner Mongolia, China.
Publication Type:Journal Article
Keywords: EGFRvIII; EGFRvIII extracellular domain; antibody library; recombinant adenovirus; single domain antibody
MeSH: Adenoviridae/genetics*; DNA, Complementary; ErbB Receptors; Escherichia coli/genetics*; Genetic Vectors/genetics*; Humans; RNA; Recombinant Proteins/metabolism*; Single-Domain Antibodies
From: Chinese Journal of Biotechnology 2022;38(9):3551-3562
CountryChina
Language:Chinese
Abstract: The aim of this study was to construct a recombinant adenovirus expressing extracellular domain gene of human epidermal growth factor receptor variant Ⅲ (EGFRvIII ECD), and to prepare single domain antibody targeting EGFRvIII ECD by immunizing camels and constructing phage display antibody library. Total RNA was extracted from human prostate cancer cell line PC-3 cells and reversely transcribed into cDNA. EGFRvIII ECD gene was amplified using cDNA as template, and ligated into pAdTrack-CMV plasmid vector and transformed into E. coli BJ5183 competent cells containing pAdEasy-1 plasmid for homologous recombination. The recombinant adenovirus expressing EGFRvIII ECD was obtained through transfecting the plasmid into HEK293A cells. The recombinant adenovirus was used to immunize Bactrian camel to construct EGFRvIII ECD specific single domain antibody library. The single domain antibody was obtained by screening the library with EGFRvIII protein and the antibody was expressed, purified and identified. The results showed that recombinant adenovirus expressing EGFRvIII ECD was obtained. The capacity of EGFRvIII specific phage single domain antibody library was 1.4×10⁹. After three rounds of enrichment and screening, thirty-one positive clones binding to EGFRvIII ECD were obtained by phage-ELISA, and the recombinant single domain antibody E14 with highest OD₄₅₀ value was expressed and purified. The recombinant E14 antibody can react with EGFRvIII ECD with high affinity in ELISA assessment. The results indicated that the EGFRvIII specific single domain antibody library with high capacity and diversity was constructed and the single domain antibody with binding activity to EGFRvIII was obtained by screening the library. This study may facilitate the diagnosis and treatment of EGFRvIII targeted malignant tumors in the future.